Equities

Genor Biopharma Holdings Ltd

Genor Biopharma Holdings Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)1.82
  • Today's Change-0.03 / -1.62%
  • Shares traded252.50k
  • 1 Year change+30.00%
  • Beta1.1546
Data delayed at least 15 minutes, as of Nov 08 2024 07:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Genor Biopharma Holdings Ltd, formerly JHBP CY Holdings Ltd, is China-based company mainly engaged in the research and development of biopharmaceutical products. The Company focuses on the development and commercialization of oncology and autoimmune drugs. The Company's main drugs include lerociclib (GB491), coprelotamab (GB221), geptanolimab (GB226), GB492, GB242 and GB223. The Company mainly conducts its businesses in the China market.

  • Revenue in HKD (TTM)15.75m
  • Net income in HKD-571.82m
  • Incorporated2017
  • Employees28.00
  • Location
    Genor Biopharma Holdings Ltd89 Nexus Way, Camana Bay,P.O. Box 31106SHANGHAI 201203ChinaCHN
  • Phone+86 2 161690700
  • Websitehttps://www.genorbio.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
6998:HKG since
announced
Transaction
value
Edding Group Co LtdAnnounced07 Oct 202407 Oct 2024Announced10.30%386.97m
Data delayed at least 15 minutes, as of Nov 08 2024 07:59 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sirnaomics Ltd0.00-635.61m265.54m90.00--140.05-----8.37-8.370.000.02160.00----0.00-110.32---136.58-------------3.26--------10.88------
Clover Biopharmaceuticals Ltd31.44m-962.22m395.60m323.00------12.58-0.7715-0.77150.0252-0.69860.01190.01498.8081,253.15-36.27---405.86--54.86---3,060.03--0.4426----------94.35------
Kintor Pharmaceutical Ltd0.00-1.00bn496.72m175.00--1.17-----2.33-2.330.000.95220.000.1411--0.00-70.41-50.15-87.57-58.43---27.62---10,511.411.56-282.630.3788-------11.15---32.49--
Antengene Corp Ltd61.01m-576.19m563.94m178.00--0.5181--9.24-0.9342-0.93420.09891.600.0350.65971.57303,530.50-33.06-53.57-37.16-58.9484.84---944.43-1,987.015.66--0.1663---57.97--3.38--202.03--
JW (Cayman) Therapeutics Co Ltd188.17m-683.18m610.65m323.00--0.3784--3.25-1.66-1.660.45623.890.07471.8711.48472,795.30-27.11-39.77-31.71-44.0050.40---363.06-1,316.812.76--0.2043--19.32--9.23---19.87--
HighTide Therapeutics Inc0.00-653.43m633.17m68.00--0.9741-----1.40-1.400.001.260.00----0.00-87.01---118.34--------------0.0404-------393.76------
Sunho Biologics Inc0.00-116.75m777.07m124.00--1.30-----0.5644-0.56440.003.81------------------------14.77-300.760.0516-------155.25------
Brii Biosciences Ltd0.00-288.84m782.34m95.00--0.2510-----0.3958-0.39580.004.260.00----0.00-8.89---9.01--------------0.007---98.80--63.90------
Immunotech Biopharm Ltd0.00-336.47m926.25m201.00--10.50-----0.6539-0.65390.000.17150.00----0.00-35.21-37.42-55.75-45.48--------0.3638-2.460.6119-------5.25---8.46--
Genor Biopharma Holdings Ltd15.75m-571.82m946.93m28.00--0.8096--60.14-1.13-1.130.0312.250.00930.01780.2277151,397.50-33.87-55.46-39.06-63.7397.5966.56-3,638.27-14,819.185.73--0.003---100.00--7.65---48.85--
Wuhan YZY Biopharma Co Ltd0.00-199.71m1.06bn114.00--19.69-----1.05-1.050.000.27840.00----0.00-83.99---230.17----------1.21--0.7078-------1.50------
TOT Biopharm International Co Ltd1.06bn9.76m1.31bn572.00125.661.6618.901.230.01350.01351.461.020.68992.446.401,921,852.000.6356-20.010.8392-25.2172.0274.740.9212-68.531.632.980.3465--76.5481.8824.36--21.04--
Jacobio Pharmaceuticals Group Co Ltd25.23m-393.79m1.40bn298.00--1.42--55.34-0.5073-0.50730.03251.250.016--2.4183,815.43-24.89-45.76-28.66-49.303.45---1,560.88-372.22----0.1794---33.66--3.43--19.18--
Data as of Nov 08 2024. Currency figures normalised to Genor Biopharma Holdings Ltd's reporting currency: Hong Kong Dollar HKD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.